Filing Details
- Accession Number:
- 0001209191-22-041761
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-11 16:00:15
- Reporting Period:
- 2022-07-07
- Accepted Time:
- 2022-07-11 16:00:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1615842 | P Barry Flannelly | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & General Manager Us | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-07-07 | 2,873 | $79.38 | 72,674 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Includes an aggregate of 48,281 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.